Detalhe da pesquisa
1.
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Lancet Oncol
; 19(3): 370-381, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29429912